Savara SVRA
NASDAQ SVRA
$4.22 -0.32 (-7.05%)
At close: Oct 23, 2026 · 4:00 PM EDT

Savara (SVRA) Amortization of Deferred Charges (2015 - 2026)

Updated

Analysis

Savara (SVRA) Amortization of Deferred Charges (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Savara 866.79 Mn 130.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43,000.00
Mar 31, 2026 160,000.00
Dec 31, 2025 126,000.00
Sep 30, 2025 128,000.00
Jun 30, 2025 129,000.00
Mar 31, 2025 70,000.00
Dec 31, 2024 68,000.00
Sep 30, 2024 68,000.00
Jun 30, 2024 67,000.00
Mar 31, 2024 68,000.00
Dec 31, 2023 68,000.00
Sep 30, 2023 68,000.00
Jun 30, 2023 67,000.00
Mar 31, 2023 68,000.00
Dec 31, 2022 68,000.00
Sep 30, 2022 68,000.00
Jun 30, 2022 45,000.00
Mar 31, 2022 153,000.00
Dec 31, 2021 139,000.00
Sep 30, 2021 136,000.00
API Access

Savara Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=SVRA&period=max&api_key=YOUR_API_KEY